In recent years, the pharmaceutical business has faced unprecedented challenges. The last three years have seen a 24% increase in the average cost of medications in the US due to safety concerns, issues with specific prescriptions, and competition from both non-generic and generic treatments. For individuals with private insurance, this led to a 4% decrease in prescription costs between 2010 and 2013.Developing nations like China, India, and Brazil have comparable difficulties. The creation of a range of vaccines with medicinal qualities is one such intervention.In order to treat bacterial illnesses and maintain population and individual health over the long term, antibiotics are required. However, bacterial diseases resistant to antibiotics pose a threat to international health.